XML 27 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Statement of Cash Flows [Abstract]      
Net income $ 447,558 $ 546,847 $ 177,305
Adjustments to reconcile net income to net cash provided by operating activities:      
Losses on early extinguishment of debt, net 10,131 274 22,503
Depreciation and amortization 153,650 153,141 147,233
Amortization of intangibles 26,195 27,650 30,956
Amortization of cemetery property 68,640 68,102 66,745
Amortization of loan costs 6,059 5,859 5,826
Provision for doubtful accounts 8,372 9,980 10,776
(Benefit from) provision for deferred income taxes (41,479) (317,838) 7,490
(Gains) losses on divestitures and impairment charges, net (15,933) (7,015) 26,819
Gain (Loss) on Sale of Investments (2,636) 0 0
Share-based compensation 15,626 14,788 14,056
Excess tax benefits from share-based awards 0 0 (12,685)
Change in assets and liabilities, net of effects from acquisitions and divestitures:      
Decrease (increase) in receivables (8,052) (9,740) (14,198)
(Increase) decrease in other assets 4,814 (14,353) 22,771
(Decrease) increase in payables and other liabilities (16,699) 81,763 47,888
Effect of preneed funeral production and maturities:      
Increase in preneed receivables, net and trust investments 55,607 (63,994) (73,394)
Increase in deferred revenue, net (28,005) 31,182 34,775
Decrease in deferred receipts held in trust 19,290 (23,274) (25,831)
Net cash provided by operating activities 615,830 503,372 489,035
Cash flows from investing activities:      
Capital expenditures (235,545) (214,501) (193,446)
Acquisitions, net of cash acquired (194,824) (76,171) (72,859)
Proceeds from divestitures and sales of property and equipment 37,309 52,381 51,813
Payments for (Proceeds from) Other Investing Activities 14,525 (175) 0
Proceeds from Sale, Maturity and Collection of Investments 2,900 0 0
Payment to Acquire Life Insurance Policy, Investing Activities (14,760) (7,360) (9,050)
Proceeds from Life Insurance Policy 4,824 2,592 2,517
Net cash used in investing activities (414,621) (242,884) (221,025)
Cash flows from financing activities      
Proceeds from issuance of long-term debt 396,349 1,787,500 1,060,000
Debt issuance costs 0 (12,939) (5,232)
Scheduled payments of debt (34,134) (468,973) (36,414)
Early payments of debt (259,590) (1,117,512) (895,634)
Principal payments on capital leases (39,686) (51,106) (33,119)
Proceeds from exercise of stock options 24,517 33,611 17,662
Excess tax benefits from share-based awards 0 0 12,685
Purchase of Company common stock (277,611) (199,637) (227,928)
Payments of dividends (123,849) (108,750) (98,418)
Purchase of noncontrolling interest 0 (4,580) (1,961)
PaymentsToAcquireBusinessesIncludiing1031ExchangeFunds 62,800 76,200 72,900
Bank overdrafts and other (15,177) 5,959 (1,095)
Net cash (used in) provided by financing activities (329,181) (136,427) (209,454)
Effect of foreign currency (5,045) 5,034 1,857
Net (decrease) increase in cash, cash equivalents, and restricted cash (133,017) 129,095 60,413
Cash, cash equivalents, and restricted cash at beginning of period 330,039    
Cash, cash equivalents, and restricted cash at end of period 198,850 330,039  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 207,584 $ 340,601 $ 211,506